Cameron Turtle
Chief Executive Officer bij SPYRE THERAPEUTICS, INC.
Vermogen: 28 M $ op 31-03-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Russell Cox | M | 60 | 9 jaar | |
Tomas Kiselak | M | 38 | 1 jaar | |
Peter Harwin | M | 38 | 1 jaar | |
Michael Henderson | M | 34 | 1 jaar | |
Heidy Abreu King-Jones | F | 41 | 1 jaar | |
Scott Burrows | M | 47 | 1 jaar | |
Jeffrey Albers | M | 52 | 1 jaar | |
Scott W. Rowlinson | M | 56 | 10 jaar | |
Laurie Stelzer | F | 56 | 1 jaar | |
Mark Mckenna | M | 48 | - | |
Paul Fehlner | M | 61 | 1 jaar | |
Joshua Friedman | M | - | 1 jaar | |
Deanna Nguyen | M | - | 1 jaar | |
Mira Huyghe | F | - | 1 jaar | |
Brian Connolly | M | - | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Armen Shanafelt | M | 64 | 10 jaar | |
Ivana Magovcevic-Liebisch | M | 55 | 5 jaar | |
V. Lawlis | M | 72 | 5 jaar | |
Hunter Smith | M | 56 | 2 jaar | |
Alison Lawton | F | 62 | 4 jaar | |
Cortney Caudill | F | - | 4 jaar | |
Marcio Souza | M | 45 | 2 jaar | |
Shafique Virani | M | 53 |
CoA Therapeutics, Inc.
CoA Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of BridgeBio Pharma, Inc., CoA Therapeutics, Inc. is a biotechnology company based in San Francisco, CA. The private company is targeting coenzyme-A (CoA) for patients with PKAN, organic acidurias, and other diseases of CoA sequestration. CoA plays a crucial role in energy metabolism and is implicated in a large number of disorders, from ultra-rare diseases like pantothenate kinase-associated neurodegeneration (PKAN) and organic acidurias (OAs), to common diseases such as type 2 diabetes. CoA Therapeutics is developing a novel small-molecule approach to modulate CoA levels by leveraging recent research about the CoA synthetic pathway. The company's approach and lead compounds are based on breakthrough scientific developments led by Suzanne Jackowski, Charles Rock, Richard Lee, and Stephen White at St. Jude Children's Research Hospital.
Navire Pharma, Inc.
Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Navire Pharma, Inc. engages in the development of therapeutics to treat multiple cancers. It focuses on SHP2, a protein-tyrosine phosphatase that links growth factor, cytokine and integrin signalling with the downstream RAS/ERK MAPK pathway to regulate cellular proliferation and survival. The company was founded by Phil Jones and Benjamin Neel in 2017 and is headquartered in San Francisco, CA. | 2 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 23 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Cameron Turtle
- Persoonlijk netwerk